Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Lytenava 25 mg/mL solution for injection {equilateral_black_triangle}

Active Ingredient:
ATC code: 
S01LA08
{info_black}
About Medicine
Outlook Therapeutics Ltd
Company image
Address
Leavesden Park Suite 1, 5 Hercules Way, Watford, Hertfordshire, WD25 7GS, UK
Telephone
+44 (0)20 3872 3526
Medical Information Direct Line
+44 (0)20 3872 3526
Medical Information e-mail
[email protected]